Sanara MedTech PE Ratio 2014-2025 | SMTI

Current and historical p/e ratio for Sanara MedTech (SMTI) from 2014 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Sanara MedTech PE ratio as of June 13, 2025 is 0.00.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

Sanara MedTech PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2025-06-13 28.81 0.00
2025-03-31 30.87 $-1.34 0.00
2024-12-31 33.20 $-1.14 0.00
2024-09-30 30.24 $-0.99 0.00
2024-06-30 28.22 $-0.78 0.00
2024-03-31 37.00 $-0.59 0.00
2023-12-31 41.10 $-0.52 0.00
2023-09-30 31.13 $-1.00 0.00
2023-06-30 40.10 $-1.05 0.00
2023-03-31 41.25 $-1.25 0.00
2022-12-31 45.50 $-1.52 0.00
2022-09-30 29.69 $-1.49 0.00
2022-06-30 20.86 $-1.58 0.00
2022-03-31 28.48 $-1.32 0.00
2021-12-31 29.55 $-1.08 0.00
2021-09-30 34.29 $-0.64 0.00
2021-06-30 36.95 $-0.55 0.00
2021-03-31 31.15 $-0.57 0.00
2020-12-31 49.90 $-0.79 0.00
2020-09-30 28.00 $-1.29 0.00
2020-06-30 18.00 $-1.46 0.00
2020-03-31 10.09 $-1.43 0.00
2019-12-31 16.10 $-1.04 0.00
2019-09-30 8.50 $-0.50 0.00
2019-06-30 5.51 $-0.15 0.00
2019-03-31 5.95 0 0.00
2018-12-31 3.27 0 0.00
2018-09-30 6.99 0 0.00
2018-06-30 6.50 0 0.00
2018-03-31 4.82 0 0.00
2017-12-31 6.00 0 0.00
2017-09-30 7.00 0 0.00
2017-06-30 7.80 0 0.00
2017-03-31 9.10 $-1.00 0.00
2016-12-31 3.79 $-1.00 0.00
2016-09-30 4.20 $-1.00 0.00
2016-06-30 6.95 $-1.00 0.00
2016-03-31 7.50 $-1.00 0.00
2015-12-31 8.85 $-1.00 0.00
2015-09-30 7.24 $-1.00 0.00
2015-06-30 9.10 $-1.00 0.00
2015-03-31 6.20 0 0.00
2014-12-31 5.50 0 0.00
2014-09-30 9.00 0 0.00
2014-06-30 10.60 0 0.00
2014-03-31 11.50 0 0.00
2013-12-31 10.50 0 0.00
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.256B $0.087B
Wound Management Technologies Inc. develops and markets wound care products. It develops, markets and distributes biotechnology products to physicians, hospitals and clinics. The Company markets collagen-based products for the treatment of pressure ulcers, diabetic ulcers, surgical wounds, ulcers due to arterial insufficiency, traumatic wounds, first and second degree burns and superficial wounds. It sells and distributes CellerateRX(R) Surgical Activated Collagen(R) Adjuvant as well as HemaQuell(R) Resorbable Bone Hemostat. Wound Management Technologies Inc. is based in Fort Worth, Texas.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $235.957B 28.37
Boston Scientific (BSX) United States $147.560B 36.94
Stryker (SYK) United States $144.011B 30.11
EssilorLuxottica (ESLOY) France $127.141B 0.00
Medtronic (MDT) Ireland $111.928B 15.87
Lonza Group Ag (LZAGY) Switzerland $50.371B 0.00
Haleon (HLN) United Kingdom $48.926B 27.87
ResMed (RMD) United States $36.560B 27.46
Agilent Technologies (A) United States $33.258B 21.68
GE HealthCare Technologies (GEHC) United States $33.082B 15.71
Terumo (TRUMY) Japan $26.680B 34.65
Insulet (PODD) United States $21.438B 84.15
Koninklijke Philips (PHG) Netherlands $21.384B 15.37
Zimmer Biomet Holdings (ZBH) United States $18.060B 11.60
Baxter (BAX) United States $15.713B 11.73
Smith & Nephew SNATS (SNN) United Kingdom $12.872B 0.00
Demant (WILYY) Denmark $9.377B 0.00
Sunny Optical Technology (SNPTF) China $9.076B 0.00
Bio-Rad Laboratories (BIO) United States $6.175B 21.49
Lantheus Holdings (LNTH) United States $5.385B 13.58
Prestige Consumer Healthcare (PBH) United States $4.149B 18.54
Perrigo (PRGO) Ireland $3.664B 9.29
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Haemonetics (HAE) United States $3.367B 15.34
ICU Medical (ICUI) United States $3.250B 23.96
Envista Holdings (NVST) United States $3.127B 25.99
QuidelOrtho (QDEL) United States $1.954B 13.44
LeMaitre Vascular (LMAT) United States $1.833B 40.97
AtriCure (ATRC) United States $1.565B 0.00
Acuren (TIC) United States $1.357B 0.00
Neogen (NEOG) United States $1.200B 15.36
AdaptHealth (AHCO) United States $1.161B 11.78
Green Thumb Industries (GTBIF) United States $1.048B 23.58
BioLife Solutions (BLFS) United States $1.046B 0.00
Phibro Animal Health (PAHC) United States $0.970B 12.40
Kestra Medical Technologies (KMTS) United States $0.904B 0.00
InMode (INMD) Israel $0.844B 8.51
Evolus (EOLS) United States $0.640B 0.00
CeriBell (CBLL) United States $0.624B 0.00
Owens & Minor (OMI) United States $0.602B 4.99
Maravai LifeSciences Holdings (MRVI) United States $0.542B 0.00
Capricor Therapeutics (CAPR) United States $0.538B 0.00
Curaleaf Holdings (CURLF) Canada $0.524B 0.00
Valneva SE (VALN) France $0.510B 0.00
Surmodics (SRDX) United States $0.417B 0.00
Tilray Brands (TLRY) Canada $0.407B 0.00
SNDL (SNDL) Canada $0.339B 0.00
VAREX IMAGING (VREX) United States $0.337B 12.41
SEMPERIT AG HLD (SEIGY) Austria $0.329B 0.00
Aurora Cannabis (ACB) Canada $0.329B 58.50
Canopy Growth (CGC) Canada $0.272B 0.00
Viemed Healthcare (VMD) United States $0.263B 22.17
Sanuwave Health (SNWV) United States $0.254B 0.00
ZimVie (ZIMV) United States $0.253B 11.52
Cerus (CERS) United States $0.252B 0.00
Cresco Labs (CRLBF) United States $0.245B 0.00
Quanterix (QTRX) United States $0.235B 0.00
OraSure Technologies (OSUR) United States $0.221B 0.00
Biote (BTMD) United States $0.207B 5.82
Brainsway (BWAY) Israel $0.206B 54.50
Omeros (OMER) United States $0.199B 0.00
TriSalus Life Sciences (TLSI) United States $0.196B 0.00
Organigram Global (OGI) Canada $0.187B 0.00
High Tide (HITI) Canada $0.185B 0.00
Utah Medical Products (UTMD) United States $0.179B 14.59
Verano Holdings (VRNOF) United States $0.174B 0.00
Exagen (XGN) United States $0.152B 0.00
Vireo Growth (VREOF) United States $0.140B 0.00
FitLife Brands (FTLF) United States $0.131B 16.18
Jin Medical (ZJYL) China $0.107B 0.00
MacroGenics (MGNX) United States $0.096B 0.00
Fonar (FONR) United States $0.090B 11.64
Veru (VERU) United States $0.090B 0.00
Quipt Home Medical (QIPT) United States $0.087B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.087B 0.00
Agape ATP (ATPC) $0.084B 0.00
TerrAscend (TSNDF) Canada $0.075B 0.00
Cytosorbents (CTSO) United States $0.068B 0.00
InterCure (INCR) Israel $0.068B 0.00
Apyx Medical (APYX) United States $0.066B 0.00
Zynex (ZYXI) United States $0.064B 0.00
ImmuCell (ICCC) United States $0.059B 0.00
Jushi Holdings (JUSHF) United States $0.054B 0.00
Modular Medical (MODD) United States $0.042B 0.00
Nephros (NEPH) United States $0.041B 55.29
United-Guardian (UG) United States $0.037B 12.90
Rockwell Medical (RMTI) United States $0.032B 0.00
Cellectar Biosciences (CLRB) United States $0.019B 0.00
Allurion Technologies (ALUR) United States $0.019B 0.00
Safety Shot (SHOT) United States $0.018B 0.00
Flora Growth (FLGC) United States $0.017B 0.00
INLIF (INLF) $0.012B 0.00
Trinity Biotech (TRIB) Ireland $0.011B 0.00
Meihua Medical Technologies (MHUA) China $0.011B 0.00
Innovative Eyewear (LUCY) United States $0.008B 0.00
Senestech (SNES) United States $0.006B 0.00
IM Cannabis (IMCC) Canada $0.005B 0.00
GlucoTrack (GCTK) United States $0.003B 0.00
Akanda (AKAN) Canada $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00